- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT01779063
Promoting Adherence to Lymphedema Self-care
Promoting Adherence to Lymphedema Self-care in Breast Cancer Survivors
Lymphedema is a chronic condition that causes physical and emotional challenges to breast cancer survivors. As a progressive condition, lymphedema can result in swelling/fibrosis that can impair function, promote infection, and cause discomfort and emotional distress. Daily self-care that is required to manage lymphedema is time-consuming, burdensome, and lifelong. Previous studies found that about half of breast cancer survivors with lymphedema do not complete self-care as directed. Feelings of being helpless to manage the condition, a desire to be normal, lack of noticeable results from self-care, and poor social/healthcare professional support are barriers to performing self-care on a regular basis. There is a need to develop and test interventions to promote effective self-care. Experts suggest the best self-care interventions should include patient perspectives and be available a readily accessible format. Technological advancements support use of innovative, creative approaches, such as Web-based multimedia interventions. Web-based interventions can be used in rural and urban settings. The investigators are proposing to develop a Web-based, multimedia intervention and a "take home" manual to support self-care in breast cancer survivors with lymphedema. The investigators plan to conduct focus groups with these survivors to determine the content and delivery format(s) and to help us identify breast cancer survivors with lymphedema for the video component. The investigators will then develop an intervention that will include self-care demonstrations and other supportive information to help patients to cope with the challenges of self-care. The focus groups will reconvene, review the intervention, and give us feedback on modifying and refining the intervention. After finalizing the intervention, The investigators will recruit more breast cancer survivors with lymphedema and provide one half of them an education booklet and the other half the Web-based intervention (or an alternative format such as DVD). Then, over 12 months, the investigators will periodically assess and compare both groups on self-care behaviors, physical and emotional concerns, and other issues such as money spent on lymphedema treatment. The group that receives the education booklet will be given access to the Web-based intervention after the 12 month follow-up is done, but the investigators will not ask them to complete any more forms.
This project builds upon the investigators prior work that has provided information about lymphedema self-care problems and the investigators previous experience in developing patient education videos and manuals. By providing accessible, detailed self-care instructions and a psychosocial component, this intervention has the potential to improve lymphedema self-care. If successful, this intervention can be offered to the larger national and international community of breast cancer survivors with lymphedema.
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Studietype
Registrering (Faktiske)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
Tennessee
-
Nashville, Tennessee, Forente stater, 37072
- Vanderbilt Univeristy School Of Nursing
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- have a history of breast cancer;
- previous diagnosis of lymphedema;
- Stage II lymphedema based upon International Society of Lymphedema (the limb is firm in places, elevation does not reduce swelling, it may or may not pit with pressure, and skin changes may be noted);
- be age 18 or older;
- be able to see and read printed documents in English; and for stage 2 only,
- have access to the Internet or a smart phone.
Exclusion Criteria: will not be:
- undergoing chemotherapy or radiation, or
- receiving hospice care. Additional exclusion criteria for local participants undergoing bioelectrical impedance measurements: pregnancy, metal implants, and defibrillator implants.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Støttende omsorg
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: web based multimedia intervention
interactive,web based multimedia intervention
|
cognitive therapy based web intervention
|
|
Aktiv komparator: education booklet
printed educational booklet
|
patient education booklet
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
symptom burden
Tidsramme: change between baseline and 1, 3, 6, and 12 months post-intervention
|
self-report of symptoms will be documented on study instruments
|
change between baseline and 1, 3, 6, and 12 months post-intervention
|
|
function
Tidsramme: change between baseline and 1, 3, 6, and 12 months post-intervention
|
Self-report functional data using a validated instrument
|
change between baseline and 1, 3, 6, and 12 months post-intervention
|
|
psychological well-being
Tidsramme: change between baseline and 1, 3, 6, and 12 months post-intervention
|
self-report using a validated instrument
|
change between baseline and 1, 3, 6, and 12 months post-intervention
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
coping
Tidsramme: change between baseline and 1, 3, 6, and 12 months post-intervention
|
self-report using validated instrument
|
change between baseline and 1, 3, 6, and 12 months post-intervention
|
|
self-care activities
Tidsramme: Change between baseline 1, 3, 6, and 12 months post-intervention
|
self report using a self-care checklist
|
Change between baseline 1, 3, 6, and 12 months post-intervention
|
|
stress
Tidsramme: change between baseline and 1, 3, 6, and 12 months post-intervention
|
self-report using a validated instrument
|
change between baseline and 1, 3, 6, and 12 months post-intervention
|
|
self-efficacy
Tidsramme: change between baseline and 1, 3, 6, and 12 months post-intervention
|
self-report using a validated instrument
|
change between baseline and 1, 3, 6, and 12 months post-intervention
|
|
social support
Tidsramme: change between baseline and 1, 3, 6, and 12 months post-intervention
|
self-report using a validated instrument
|
change between baseline and 1, 3, 6, and 12 months post-intervention
|
|
extracellular fluid
Tidsramme: change between baseline and 3, 6, and 12 months post-intervention
|
bioelectrical impedence measurement for sub set of participants
|
change between baseline and 3, 6, and 12 months post-intervention
|
Samarbeidspartnere og etterforskere
Sponsor
Samarbeidspartnere
Studierekorddatoer
Studer hoveddatoer
Studiestart
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Anslag)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- 124137-RSG-13-022-01-CPPB
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .